Status:
RECRUITING
Connective Tissue Diseases and Lung Manifestations
Lead Sponsor:
Medical University Innsbruck
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Connective Tissue Diseases
Interstitial Lung Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Despite a number of prospective studies already initiated in the past years, the current epidemiology and course of interstitial lung disease (ILD) and pulmonary hypertension (PH) in patients with con...
Detailed Description
Specifically, this registry will collect demographic data, disease-related clinical data, routine laboratory values (including antibody-profile and iron status), diagnostic procedures, significant com...
Eligibility Criteria
Inclusion
- The inclusion criteria are adult patients (≥18 years) diagnosed with CTD with signed informed consent.
Exclusion
- Exclusion criteria are patients with a serious co-morbidity interfering with the course of interstitial lung disease or pulmonary hypertension.
Key Trial Info
Start Date :
December 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2034
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04095351
Start Date
December 9 2019
End Date
October 1 2034
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Innsbruck, Department of Internal Medicine II
Innsbruck, Austria, 6020